Immune respons after TB-vaccinatio

• Conditions: BCG vaccination / immune respons; Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]

• Registration Number: EUCTR2011-005653-31-NL
• Lead Sponsor: MC, Department Infection Disease

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04-27
• Last Update Posted: 3 July 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Healthy
Age 18-55 year
Naieve tuberculose volunteers (negaitve TST and negative QFN-test)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

History of TB disease or treatment
BCG vaccination
HIV-positive
Pregancy breastfeeding

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified